Commonwealth Equity Services’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,950
Closed -$40K 4447
2025
Q3
$40K Sell
24,950
-55,000
-69% -$55.4K ﹤0.01% 4178
2025
Q2
$49K Buy
79,950
+20,450
+34% +$10.4K ﹤0.01% 4158
2025
Q1
$34K Buy
59,500
+15,000
+34% +$14.8K ﹤0.01% 4099
2024
Q4
$64K Buy
+44,500
New +$99.8K ﹤0.01% 3965

Other funds holding TNYA

Commonwealth Equity Services's TNYA Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 24,950 shares — an estimated $40K sold.

Commonwealth Equity Services first reported a position in TNYA in Q4 2024 and held it in 4 quarters. The position peaked at $64K in Q4 2024. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 24,950 Tenaya Therapeutics shares in Q4 2025, an estimated $40K.
  • Commonwealth Equity Services first reported a position in Tenaya Therapeutics in Q4 2024 and held it in 4 quarters.
  • Commonwealth Equity Services's Tenaya Therapeutics position peaked at $64K in Q4 2024.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.